Point72 Europe’s CareDx CDNA Stock Holding History

Point72 Europe’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,394	Closed	-$40.7K	–	165
2023 Q4	$40.7K	Buy	+3,394	New	+$27.8K	0.01%	322

Other funds holding CDNA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Europe's CDNA Position: Q1 2024 in Review

Point72 Europe sold out of CareDx (CDNA) in Q1 2024, closing a stake of 3,394 shares — an estimated $40.7K sold.

Point72 Europe first reported a position in CDNA in Q4 2023 and held it in 1 quarter. The position peaked at $40.7K in Q4 2023. 147 funds tracked by Wall St. Rank hold CDNA as of Q1 2024.

Point72 Europe reported no remaining CareDx position as of Q1 2024 after selling out during the quarter.
Point72 Europe sold 3,394 CareDx shares in Q1 2024, an estimated $40.7K.
Point72 Europe first reported a position in CareDx in Q4 2023 and held it in 1 quarter.
Point72 Europe's CareDx position peaked at $40.7K in Q4 2023.
147 funds tracked by Wall St. Rank held CareDx as of Q1 2024.

Based on Point72 Europe's 13F filing for Q1 2024, filed 15 May 2024.